Development and Validation of Stability-Indicating Assay Method by RP-HPLC for Simultaneous Estimation of Rosuvastatin Calcium and Fenofibrate in Pharmaceutical Dosage Form
A Simple, precise, and accurate stability-indicating reversed-phase high-performance liquid chromatography method has been established for the simultaneous estimation of rosuvastatin calcium and fenofibrate in combined bulk and tablet formulation. The chromatographic separation was performed on reverse phase Princeton (C18) (250 mm x 4.6 mm, 5µ) column with mobile phase as a mixture of water (pH adjusted to 3.0 with orthophosphoric acid) and acetonitrile in the ratio (40:60) v/v at the flow rate 1.0 ml/min. Detection was carried out at wavelength 240 nm. The retention time under the optimized condition of Rosuvastatin calcium and Fenofibrate was found to be 2.485 & 3.905 minutes respectively. The calibration curve was linear in the range of 6-16 µg/ml and 87-232 µg/ml for rosuvastatin calcium and fenofibrate with a correlation coefficient of 0.9999 and 0.9994 respectively. Relative standard deviation values for all key parameters were less than 2.0%. The percentage recovery was found to be 99.66-100.37% and 99.13-100.44% for rosuvastatin calcium and fenofibrate respectively. The developed reversed-phase high-performance liquid chromatography method was found to be simple, specific, sensitive, rapid, linear, accurate, precise, and economical, and could be used for regular quality control of rosuvastatin calcium and fenofibrate in bulk and tablet formulations.
Keywords: Rosuvastatin calcium, Fenofibrate, RP-HPLC, Method validation, ICH guidelines.
2. P.D. Martin, M.J. Warwick, A.L. Dane, S.J. Hill, P.B. Giles, P.J. Phillips and E. Lenz. Clin Ther, 2003;25,2822.
3. Remington -The science and practice of pharmacy, 21st ed. Lippincott Williams & Wilkins, 2006;1368.
4. Sweetman SC. Martindale: The Complete Drug Reference. London, England, UK: Pharmaceutical Press, 2002.
5. Sever PS, Poulter NR, Dahlof B, Wewdwl H. Different Time Course for Prevention of coronary and Stroke Events by Atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial- Lipid – Lowering Arm. Amer J Cardio, 2005;96:39-44.
6. Pandya CP, Rajput SJ. Stress Degradation Studies of Riociguat, Development of Validated Stability Indicating Method, Identification, Isolation and Characterization of Degradation Products by LC-HR-MS/MS and NMR Studies. Ind J Pharm Edu and Res, 2019 Oct 1; 53(4):S630-41.
7. Bockhorn H, Hornung A, Hornung U, Schawaller D. Kinetic study on the thermal degradation of polypropylene and polyethylene. J Ana and Appl Pyro, 1999 Jan 1;48(2):93-109.
8. Shrimali C, Baghel M, Rajput S. Development and validation of stability indicating RP-HPLC method of nepafenac and its degradation products: application to degradation kinetic. Int J Pharm Pharm Sci, 2014;6(9):387-93.
9. Sailaja B, Sravan Kumari K. Stability-Indicating Method Development and Validation for The Estimation of Rosuvastatin Calcium in Bulk and Tablet Formulation by Reverse-Phase High-Performance Liquid Chromatography. Asian J Pharm Clin Res, 2019;12:251-256.
10. Rajput P, Shah DB, Maheshwari DG. A review on chromatographic method for estimation of Rosuvastatin calcium. Int J Res Pharmacy Pharm Sci, 2018;3:28-31.
11. Thammera RK, Shitut NR, Pasikanti KK, Menon VCA, Venkata VPK, Mullangi R. Determination of Rosuvastatin in rat plasma by HPLC and its application to pharmacokinetic studies. Biomed Chromatogr, 2006;20:881-887.
12. Hassouna ME, Salem HO. Stability indicating new RP-HPLC method for the determination of rosuvastatin calcium in pure and tablets dosage forms. Int J Appl Pharm Bio Res, 2017;2:11-27.
13. Sirisha Mulukuri NV, Srinivasarao T, Raveendra BG. New RP-HPLC method development and validation for the estimation of rosuvastatin calcium in bulk drugs and formulations. J Pharm Res, 2017;11:257-260.
14. Hasumati AR, Rajput SJ, Dave JB, Patel CN. Development and validation of two chromatographic stability-indicating methods for determination of rosuvastatin in pure from and pharmaceutical preparation. Int J Chem Tech Res, 2009;1:677-689.
15. Kadav A, Vora DN, Stability indicating UPLC method for simultaneous determination of Atorvastatin calcium, Fenofibrate and their degradation products in Tablets, J Pharm and Biomed Ana, 2008;48:120-126.
16. Madala A, Keerthisikha P. A New Stability Indicating Method Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Rosuvastatin Calcium and Fenofibrate in Tablet Dosage Form. Indo Amer J Pharm Sci, 2016;3:953-959.
17. Anusha, B, Geetha Susmita A, Rajitha G. Analytical Method Development and Validation of New RP-HPLC Method for Simultaneous Estimation of Brinzolamide and Timolol Maleate in Ophthalmic Solutions. Res J Pharm Bio Chem Sci, 2016;7(3):1290-1298.
18. ICH, Q1A, Stability Testing of New Drug Substances and Products, in: Proceedings of the International Conference on Harmonisation, Geneva, October, 1993.
19. Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_ Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).